Bcl2 Modifying Factor (BMF) (N-Term) Peptid
BMF
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5510985
Kurzübersicht für Bcl2 Modifying Factor (BMF) (N-Term) Peptid (ABIN5510985)
Target
BMF
(Bcl2 Modifying Factor (BMF))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- MEPSQCVEEL EDDVFQPEDG EPVTQPGSLL SADLFAQSLL DCPLSRLQLF
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BMF Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BMF (Bcl2 Modifying Factor (BMF))
-
Hintergrund
-
The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein contains a single BCL2 homology domain 3 (BH3), and has been shown to bind BCL2 proteins and function as an apoptotic activator. This protein is found to be sequestered to myosin V motors by its association with dynein light chain 2, which may be important for sensing intracellular damage and triggering apoptosis. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: BMF,
Protein Size: 129 -
Gen-ID
- 90427
Target
-
Sie sind hier:
